TrialClinical breast cancer2017

HALT-D: A Phase II Evaluation of Crofelemer for the Prevention and Prophylaxis of Diarrhea in Patients With Breast Cancer on Pertuzumab-Based Regimens.

Jennifer J Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.